I
PODD
Insulet Corp
143.34
-3.10-2.12%After Hours: 144.03 +0.69 +0.48%19:57 08/14 EDT
OPEN/PREV CLOSE146.87/146.87
TODAY RANGE145.07-150.20
VOL410.62K
MARKET CAP10.36B
52 WEEK RANGE126.40-354.88
AVG VOL (3M)1.60M
% TURNOVER0.59%
TURNOVER--
P/E (TTM)27.94
% RANGE3.50%
EPS(TTM)5.35
P/E(FORWARD)24.45
P/B7.28
BVPS20.51
DIVIDEND--
P/S3.883
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP10.32B
SHARES OUTSTANDING69.35M
NEXT EARNINGS11/04-11/09
FREE FLOAT69.11M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Dow Jones·2d ago
Insulet Corp. Stock Rises 6.0%, Outperforms Peers
MarketWatch·2d ago
Insulet Corp. stock outperforms competitors on strong trading day
TipRanks·5d ago
Insulet participates in a conference call with JPMorgan
Simply Wall St·6d ago
Does Stronger Q2 Results And Higher Guidance Change The Bull Case For Insulet (PODD)?
TipRanks·08/13 16:15
Insulet (PODD) Receives a Hold from Citi
NASDAQ·08/13 13:45
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
Simply Wall St·08/12 15:31
Insulet (PODD) Could Be 39% Undervalued After Strong Earnings And Higher 2026 Outlook
TipRanks·08/12 12:00
Wall Street Analysts Are Neutral on Top Healthcare Picks
Seeking Alpha·08/09 13:05
Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Pfizer in focus
Simply Wall St·08/08 13:32
Insulet Corporation (NASDAQ:PODD) Just Reported, And Analysts Assigned A US$172 Price Target
Simply Wall St·08/07 13:29
Insulet (PODD) Is Down 15.9% After Cutting 2026 Revenue Guidance on Type 2 Retention Strains
Dow Jones·08/06 23:07
Insulet Price Target Cut to $179.00/Share From $249.00 by Canaccord Genuity
Same Industry
Name/Symbol
Change%
Price